LFMD Q2 2021 Earnings — LifeMD, Inc. Revenue & Financial Results | Market Cap Arena

LFMDLifeMD, Inc.

$200M

Q2 2021 Earnings

Healthcare Medical - Pharmaceuticals

Income Statement

Revenue

$22M+145.5% YoY

Gross Profit

$18M81.5% margin

Operating Income

-$16M-72.3% margin

Net Income

-$17M-75.4% margin

EPS (Diluted)

$-0.64

QoQ Revenue Growth

+22.6%

Cash Flow

Operating Cash Flow

-$11M

Free Cash Flow

-$12M

Stock-Based Comp.

$3M

Balance Sheet

Total Assets

$24M

Total Liabilities

$28M

Stockholders' Equity

-$3M

Cash & Equivalents

$17M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$22M	$9M	+145.5%
Gross Profit	$18M	$7M	+163.7%
Operating Income	-$16M	-$3M	-401.1%
Net Income	-$17M	-$3M	-398.1%

Revenue Segments

Software Revenues Net

$7M100%